Results 61 to 70 of about 12,259 (202)

Bromocriptine for Idiopathic Intracranial Hypertension: A Retrospective Multicenter Cohort Study [PDF]

open access: yes
Mahmoud M Morsy,1,* Ahmed Y Azzam,1,* Mohammed Tarek Mirdad,2 Alsaleem Mohammed Abadi,3 Saif Aboud M Alqahtani,4 Hana J Abukhadijah,5 Osman Elamin,6 Mohamed D Morsy,7 David J Altschul8,9 1October 6 University Hospital, October 6 University, Giza,
Abadi AM   +8 more
core  

Prolactin [PDF]

open access: yes, 1977
During an oral glucose tolerance test (OGTT) glucose and insulin levels were measured in 26 patients with prolactin-producing pituitary tumours without growth hormone excess.
Hörl, R.   +5 more
core   +1 more source

DRD2 Deficiency Underlies Pituitary Adenoma Dependent on Escherichia coli Translocation from the Gut

open access: yesAdvanced Science, Volume 13, Issue 24, 27 April 2026.
Dopamine receptor D2 (DRD2) deficiency disrupts epithelial barrier integrity in both the gut and pituitary gland, facilitating translocation of gut‐derived Escherichia coli into pituitary tissue. Intratumoral E. coli are phagocytosed by microglia, triggering GSDMD‐dependent pyroptosis and HMGB1 release, which subsequently activates MAPK signaling to ...
Xian‐jun Su   +16 more
wiley   +1 more source

Effects of Bromocriptine on Dopamine Turnover with or without Levodopa

open access: yes, 1996
Bromocriptine, a dopamine agonist, alleviates symptoms of Parkinson's disease, even when administered alone, and is used for its treatment. Better therapeutic effects are, however, achieved when bromocriptine is used in combination with levodopa.
M Asanvma   +5 more
core   +1 more source

Deep Brain Stimulation and Pregnancy: A Case Report and Literature Review

open access: yes
Movement Disorders Clinical Practice, Volume 13, Issue 8, Page 2006-2009, August 2026.
Verónica Cabreira, Maria José Rosas
wiley   +1 more source

Drug‐Induced Raynaud's Phenomenon and Underlying Mechanism: A Disproportionality Analysis From the World Health Organization Pharmacovigilance Database

open access: yesArthritis &Rheumatology, Volume 78, Issue 4, Page 985-992, April 2026.
Objectives The aim of this study is to generate hypotheses about unknown drugs associated with the onset or worsening of Raynaud's phenomenon (RP) and to explore their potential pathophysiologic mechanisms through a mixed disproportionality/clustering analysis from the World Health Organization (WHO) pharmacovigilance database.
Alex Hlavaty   +4 more
wiley   +1 more source

Solid lipid nanoparticles as delivery systems for bromocriptine

open access: yes, 2008
Purpose. The present investigation describes a formulative study for the development of innovative drug delivery systems for bromocriptine. Methods.
Mariani, Paolo   +21 more
core   +1 more source

Central Hyperthermia Treated with Bromocriptine

open access: yes, 2017
Introduction. Central hyperthermia is common in patients with brain injury. It typically has a rapid onset with high temperatures and marked fluctuations and responds poorly to antibiotics and antipyretics.
P. Nattanmai   +4 more
core   +1 more source

Akinetic mutism related to hydrocephalus and cerebellar surgery treated with bromocriptine and ephedrine. A pathophysiological review

open access: yes, 2005
Akinetic mutism (AM) is a behavioral disorder characterized by impossibility to move or speak in awake patients. lt has been typically described as a transient disorder following posterior fossa tumour resection.
Iza, Begoña   +6 more
core   +1 more source

Transfer of bromocriptine across the blood-brain barrier in man

open access: yes, 1979
The transfer of 14C-bromocriptine across the blood-brain barrier was studied in 10 patients using the double indicator single injection method. The extraction (E) of bromocriptine was 8 % (quartiles: 6 and 14 %).
Hertz, M M, Paulson, O B, Friis, M L
core   +1 more source

Home - About - Disclaimer - Privacy